Evaluating the necessity for universal screening of prospective oocyte donors using enhanced genetic and psychological testing

Human Reproduction

Volumn 25, Issue 9, 2010, Pages 2298-2304

  Reh, Andrea ^a   Amarosa, Alana ^a   Licciardi, Frederick ^a   Krey, Lewis ^a   Berkeley, Alan S ^a   Kump, Lisa ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

genetic counselor; genetic screening; oocyte donation; psychological screening

Indexed keywords

AMERICAN SOCIETY OF REPRODUCTIVE MEDICINE; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DONOR SELECTION; FEMALE; FRAGILE X SYNDROME; GENETIC SCREENING; HUMAN; MINNESOTA MULTIPHASIC PERSONALITY INVENTORY; OOCYTE DONATION; PRACTICE GUIDELINE; PSYCHOLOGIC TEST; TAY SACHS DISEASE;

EID: 77955967997     PISSN: 02681161     EISSN: 14602350     Source Type: Journal    
DOI: 10.1093/humrep/deq182     Document Type: Article

References (28)

1. ASRM Practice Committee Report. Guidelines for gamete embryo donation. Fertil Steril 2008;90(Suppl. 5):S30-S44.
2. Acharya K, Ross LF. Fragile X screening: attitudes of genetic health professionals. Am J Med Genet A 2009;149A:626-632.
3. ACOG Committee Opinion. Number 318 October 2005. Screening for Tay-Sachs disease. Obstet Gynecol 2005;106:893-894.
4. ACOG Committee Opinion. No.338: Screening for fragile X syndrome. Obstet Gynecol 2006;107:1483-1485.
5. ACOG Committee Opinion. No.442: Preconception prenatal carrier screening for genetic diseases in individuals of Eastern European Jewish descent. Obstet Gynecol 2009;114:950-953.
6. Baker VL, Rone HM, Adamson GD. Genetic evaluation of oocyte donors: recipient couple preferences and outcome of testing. Fertil Steril 2008; 90:2091-2098.
7. Bustillo M, Buster JE, Cohen SW, Thorneycroft IH, Simon JA, Boyers SP, Marshall JR, Seed RW, Louw JA, Seed RG. Nonsurgical ovum transfer as a treatment in infertile women. Preliminary experience. J Am Med Assoc 1984;251:1171-1173.
8. Daar JF, Brzyski RG. Genetic screening of sperm and oocyte donors: ethical and policy implications. J Am Med Assoc 2009;302:1702-1704.
9. Evans JA, Canning N, Hunter AG, Martsolf JT, Ray M, Thompson DR, Hamerton JL. A cytogenetic survey of 14,069 newborn infants. III. an analysis of the significance and cytologic behavior of the Robertsonian and reciprocal translocations. Cytogenet Cell Genet 1978;20:96-123.
10. Fanos JH, Spangner KA, Musci TJ. Attitudes toward prenatal screening and testing for Fragile X. Genet Med 2006;8:129-133.
11. Garrido N, Zuzuarregui JL, Meseguer M, Simon C, Remohi J, Pellicer A. Sperm and oocyte donor selection and management: experience of a 10 year follow-up of more than 2100 candidates. Hum Reprod 2002; 17:3142-3148.
12. Hollingsworth B, Harris A. Economic evaluation of prenatal population screening for fragile X syndrome. Community Genet 2005;8:68-72.
13. Kaback M, Lim-Steele J, Dabholkar D, Brown D, Levy N, Zeiger K. Tay-Sachs disease: carrier screening, prenatal diagnosis, and the molecular era. An international perspective, 1970 to 1993. The International TSD Data Collection Network. J Am Med Assoc 1993;270:2307-2315.
14. Klock SC, Covington SN. Minnesota Multiphasic Personality Inventory (MMPI-2) profiles in the assessment of ovum donors. Fertil Steril 2009 Epub ahead of print Oct 13.
15. Lee SS, Cho M, Berkeley AS, Licciardi F, Noyes N, Grifo J. Analysis of abnormal MMPI-2 profiles of prospective donor gamete recipient and partners. Fertil Steril 2008;90(Suppl. 1):S10: ASRM Abstract, Sept 2008.
16. Lessor R, Cervantes N, O'Connor N, Balmaceda J, Asch RH. An analysis of social and psychological characteristics of women volunteering to become oocyte donors. Fertil Steril 1993;59:65-71.
17. Lewis V, Saller DN Jr, Kouides RW, Garza J. Survey of genetic screening for oocyte donors. Fertil Steril 1999;71:278-281.
18. Maron BJ, Lesser JR, Schiller NB, Harris KM, Brown C, Rehm HL. Implications of hypertrophic cardiomyopathy transmitted by sperm donation. J Am Med Assoc 2009;302:1681-1684.
19. Musci TJ, Caughey AB. Cost-effectiveness analysis of prenatal population-based fragile X carrier screening. Am J Obstet Gynecol 2005;192: 1905-1912. discussion 1912-1915
20. UK guidelines for the medical laboratory screening of egg embryo donors. Hum Fertil (Camb) 2008;11:201-210.
21. Rajendra K, Bringman JJ, Ward J, Phillips OP. Who should be tested for fragile X carriership? A review of 1 center's pedigrees. Am J Obstet Gynecol 2008;198:e51-e53.
22. Ravel C, Letur H, Le Lannou D, Barthelemy C, Bresson JL, Siffroi JP. High incidence of chromosomal abnormalities in oocyte donors. Fertil Steril 200787:439-441.
23. Reiss AL, Kazazian HH Jr, Krebs CM, McAughan A, Boehm CD, Abrams MT, Nelson DL. Frequency and stability of the fragile X premutation. Hum Mol Genet 1994;3:393-398.
24. Rousseau F, Rouillard P, Morel ML, Khandjian EW, Morgan K. Prevalence of carriers of premutation-size alleles of the FMRI gene-and implications for the population genetics of the fragile X syndrome. Am J Hum Genet 1995;57:1006-1018.
25. Sauer MV, Kavic SM. Oocyte and embryo donation 2006: reviewing two decades of innovation and controversy. Reprod Biomed Online 2006; 12:153-162.
26. Srinivasan B, Flannick J, Patterson AS, Chang CC, Pham T Young S, Kaushal A, Lee JJ, Patrizio P, Evans EA. A universal carrier test for the long tail of mendelian disease. 2010; Available from Nature Precedings,http://hdl.handle.net/ 10101/npre.2010.4192.1 (2010).
27. Sunderam S, Chang J, Flowers L, Kulkarni A, Sentelle G, Jeng G, Macaluso M. Assisted reproductive technology surveillance: United States, 2006. MMWR Surveill Summ 2009;58:1-25.
28. Wallerstein R, Jansen V, Grifo JA, Berkeley AS, Noyes N, Licker J, Licciardi F. Genetic screening of prospective oocyte donors. Fertil Steril 1998;70:52-55.